Combination of antilymphocyte globulin and leflunomide leads to superior grafts.
Woo
J
J
SangStat, The Transplant Company, 94555, Fremont, California, USA.
Zhang
W
W
Gao
L
L
Shen
J
J
Chong
A
A
Buelow
R
R
D000818:Animals; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D006085:Graft Survival / Q000187:drug effects* / Q000502:physiology; D016027:Heart Transplantation / Q000276:immunology*; D007074:Immunoglobulin G / Q000097:blood / Q000187:drug effects*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007555:Isoxazoles / Q000627:therapeutic use*; D000077339:Leflunomide; D011817:Rabbits; D051381:Rats; D011912:Rats, Inbred ACI; D011917:Rats, Inbred Lew; D013601:T-Lymphocytes / Q000276:immunology*; D016042:Transplantation, Heterotopic
D000961:Antilymphocyte Serum; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D007555:Isoxazoles; D000077339:Leflunomide